Table 1.

Time and events table for Assessing Predictors of Infant Respiratory Syncytial Virus Effects and Severity study.

Samples/data		Birth cohort visits			RSVa positive illness
		Birth	1 month	Illness surveillance	Acute (day 2-7)	Day 12-16	Day 25-35
Demographic		Xb	X	—c	X	X	X
Clinical		X	X	—	X	X	X
Cord blood for antibody		X	—	—	—	—	—
Buccal swab for cytomegalovirus polymerase chain reaction		X	X	—	X	—	—
Nasal swab RSV RT-PCRd		—	—	X	—	—	—
Nasal swab for:
	Quantitative RSV RT-PCR	—	—	—	X	—	X
	Viral coinfection	—	—	—	X	—	X
	RSV gene sequencing	—	—	—	X	—	X
	Microbiome	—	X	—	X	—	X
Nasal wash		—	X	—	X	—	X
Nasal brush for epithelial cell RNAseqe		—	X	—	X	—	X
Blood for:
	Peripheral blood mononuclear cells flow cytometry	—	—	—	X	X	X
	CDf4, CD8, B, natural killer RNAseq	—	—	—	X	X	—
	Antibody assays	—	—	—	X	X	X

^aRSV: respiratory syncytial virus.

^bX indicates samples at this time point.

^cIndicates no samples collected at time point.

^dRT-PCR: reverse-transcriptase polymerase chain reaction.

^eRNAseq: ribonucleic acid sequencing.

^fCD: cluster of differentiation.